InvestSMART

Antisense Therapeutics Limited (ASX: ANP) - Announcements

Current share price for ANP : $0.058 0.003 (4.92%)+

ASX company news and announcements for Antisense Therapeutics Limited (ANP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Antisense Therapeutics Limited (ANP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Antisense Therapeutics Limited (ANP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Antisense Therapeutics Limited (ANP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$52 Change in substantial holding from AEF 18 Mar 2019 10:13AM $0.040 $0.058 risen by 45%
$52 Becoming a substantial holder CityCastle Pty Ltd 15 Mar 2019 4:40PM $0.038 $0.058 risen by 52.63%
$52 Completion of $1,600,000 Share Placement 15 Mar 2019 4:37PM $0.038 $0.058 risen by 52.63%
$52 Placement to Accelerate Development of ATL1102 in DMD 13 Mar 2019 9:21AM $0.037 $0.058 risen by 56.76%
$52 Trading Halt 11 Mar 2019 9:53AM $0.037 $0.058 risen by 56.76%
$52 Pause in trading 11 Mar 2019 9:48AM $0.037 $0.058 risen by 56.76%
$52 Half Yearly Report and Accounts 27 Feb 2019 6:03PM $0.038 $0.058 risen by 52.63%
$52 Appendix 4C - quarterly 30 Jan 2019 9:44AM $0.038 $0.058 risen by 52.63%
$52 Updated Company Presentation 23 Jan 2019 8:52AM $0.036 $0.058 risen by 61.11%
$52 Phase II clinical trial in DMD Update 18 Jan 2019 9:03AM $0.028 $0.058 risen by 107.14%
$52 Receipt of R&D Tax Incentive payment 4 Dec 2018 8:57AM $0.032 $0.058 risen by 81.25%
$52 Results of Meeting 29 Nov 2018 12:52PM $0.035 $0.058 risen by 65.71%
$52 AGM Presentation 29 Nov 2018 11:01AM $0.039 $0.058 risen by 48.72%
$52 Appendix 4G 9 Nov 2018 11:12AM $0.038 $0.058 risen by 52.63%
$52 Investor Presentation 30 Oct 2018 9:12AM $0.048 $0.058 risen by 20.83%
$52 Notice of Annual General Meeting/Proxy Form 29 Oct 2018 9:41AM $0.039 $0.058 risen by 48.72%
$52 Appendix 4C - quarterly 29 Oct 2018 9:30AM $0.039 $0.058 risen by 48.72%
$52 Response to ASX Price and Volume Query 16 Oct 2018 3:04PM $0.036 $0.058 risen by 61.11%
$52 Duchenne ACTT Now Conference 2018 6 Sep 2018 9:15AM $0.021 $0.058 risen by 176.19%
$52 Full Year Statutory Accounts 29 Aug 2018 4:26PM $0.022 $0.058 risen by 163.64%
$52 First Patient Dosed in Phase II DMD Clinical Trial 29 Aug 2018 10:38AM $0.021 $0.058 risen by 176.19%
$52 Pause in Trading 29 Aug 2018 10:10AM $0.021 $0.058 risen by 176.19%
$52 ANP to Present at 14th Annual Bioshares Biotech Summit 27 Jul 2018 9:37AM $0.026 $0.058 risen by 123.08%
$52 Change of Director's Interest Notice (RM) 26 Jul 2018 9:32AM $0.025 $0.058 risen by 132%
$52 Appendix 4C - quarterly 24 Jul 2018 7:19PM $0.026 $0.058 risen by 123.08%

301 - 325 of 707 results

Page 13 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.